Yareli Rojas-Aguirre, Karina Aguado-Castrejón, Israel González-Méndez
{"title":"La nanomedicina y los sistemas de liberación de fármacos: ¿la (r)evolución de la terapia contra el cáncer?","authors":"Yareli Rojas-Aguirre, Karina Aguado-Castrejón, Israel González-Méndez","doi":"10.1016/j.eq.2016.07.002","DOIUrl":null,"url":null,"abstract":"<div><p>The term nanotechnology refers to a number of disciplines intended to study materials and structures at the nanoscale. One of the most important areas of nanotechnology is nanomedicine, which is focused in great extent on the design and development of drug delivery systems. These drug delivery platforms can display very sophisticated properties and unique features, and are considered as the revolution of the conventional chemotherapies, specifically those to treat cancer. In this work we review the concept of nanomedicine and its application on the design of nanocarriers of antineoplastic drugs and highlight some aspects that have to be addressed to translate the drug delivery platforms in to devices with possibilities to reach clinical trials.</p></div>","PeriodicalId":39011,"journal":{"name":"Educacion Quimica","volume":"27 4","pages":"Pages 286-291"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eq.2016.07.002","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Educacion Quimica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0187893X16300295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 8
Abstract
The term nanotechnology refers to a number of disciplines intended to study materials and structures at the nanoscale. One of the most important areas of nanotechnology is nanomedicine, which is focused in great extent on the design and development of drug delivery systems. These drug delivery platforms can display very sophisticated properties and unique features, and are considered as the revolution of the conventional chemotherapies, specifically those to treat cancer. In this work we review the concept of nanomedicine and its application on the design of nanocarriers of antineoplastic drugs and highlight some aspects that have to be addressed to translate the drug delivery platforms in to devices with possibilities to reach clinical trials.